Neonc Technologies (NTHI) to Release Quarterly Earnings on Friday

Neonc Technologies (NASDAQ:NTHI) is expected to be announcing its results before the market opens on Friday, February 20th. Analysts expect the company to announce earnings of ($0.37) per share for the quarter.

Neonc Technologies Trading Down 9.6%

Shares of NASDAQ NTHI opened at $9.26 on Wednesday. The firm’s 50 day moving average price is $9.10 and its 200-day moving average price is $8.87. Neonc Technologies has a 52-week low of $3.20 and a 52-week high of $25.00.

Insider Buying and Selling at Neonc Technologies

In other news, President Amir F. Heshmatpour purchased 24,000 shares of the stock in a transaction dated Friday, November 21st. The shares were purchased at an average cost of $6.07 per share, with a total value of $145,680.00. Following the acquisition, the president directly owned 2,986,000 shares of the company’s stock, valued at $18,125,020. This represents a 0.81% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Over the last quarter, insiders acquired 31,100 shares of company stock worth $192,099.

Institutional Trading of Neonc Technologies

A number of hedge funds have recently bought and sold shares of NTHI. Bank of America Corp DE lifted its holdings in Neonc Technologies by 1.0% in the third quarter. Bank of America Corp DE now owns 226,486 shares of the company’s stock valued at $2,056,000 after acquiring an additional 2,207 shares during the period. State Street Corp increased its position in shares of Neonc Technologies by 9.9% during the 4th quarter. State Street Corp now owns 43,170 shares of the company’s stock valued at $357,000 after purchasing an additional 3,900 shares during the last quarter. Barclays PLC lifted its stake in shares of Neonc Technologies by 5,314.8% in the 4th quarter. Barclays PLC now owns 9,151 shares of the company’s stock worth $76,000 after purchasing an additional 8,982 shares during the period. Goldman Sachs Group Inc. purchased a new position in shares of Neonc Technologies in the fourth quarter worth approximately $124,000. Finally, OMERS ADMINISTRATION Corp bought a new stake in Neonc Technologies during the fourth quarter valued at approximately $126,000.

Wall Street Analysts Forecast Growth

NTHI has been the topic of several analyst reports. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Neonc Technologies in a research report on Monday, December 29th. Zacks Research raised Neonc Technologies to a “hold” rating in a report on Wednesday, January 14th. One research analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company currently has an average rating of “Reduce”.

Neonc Technologies Company Profile

Neonc Technologies Holdings, Inc develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing. The company was incorporated in 2023 and is based in Los Angeles, California.